Understanding Healthcare Providers’ Care for Patients with Medications Treating Opioid Use Disorder in the Emergency Department: A Scoping Review

References

• Alinsky, R. H., Silva, C., Adger, H., & McGinty, E. E. (2022). Research to law: A qualitative study of Massachusetts’ 2018 Care Act expanding emergency department initiation of medication for opioid use disorder. Journal of Substance Abuse Treatment, 141, 108803. https://doi.org/10.1016/j.jsat.2022.108803
   PubMed Web of Science ®Google Scholar
• Arksey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616
   Google Scholar
• Azubike, N., Moseley, M., & Powers, J. S. (2021). Opioid management in older adults: Lessons learned from a geriatric patient-centered medical home. Federal Practitioner: For the Health Care Professionals of the VA, DoD, and PHS, 38(4), 168–173. https://doi.org/10.12788/fp.0110
   PubMedGoogle Scholar
• Barcelona, V., Wischik, D. L., Marshall, A., & Tetrault, J. M. (2022). Integration of medication for opioid use disorder training into graduate nursing education. Nursing Forum, 57(5), 869–873. https://doi.org/10.1111/nuf.12753
   PubMed Web of Science ®Google Scholar
• Brackett, C. D., Duncan, M., Wagner, J. F., Fineberg, L., & Kraft, S. (2022). Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model. Substance Abuse, 43(1), 240–244. https://doi.org/10.1080/08897077.2021.1932698
   PubMed Web of Science ®Google Scholar
• Bronfenbrenner, U. (1992). Ecological systems theory. In Six theories of child development: Revised formulations and current issues (pp. 187–249). Jessica Kingsley Publishers.
   Google Scholar
• Campbell, C. I., Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., … Bradley, K. A. (2021). PRimary care opioid use disorders treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addiction Science & Clinical Practice, 16(1), 9. https://doi.org/10.1186/s13722-021-00218-w
   PubMed Web of Science ®Google Scholar
• Cao, S. S., Dunham, S. I., & Simpson, S. A. (2020). Prescribing buprenorphine for opioid use disorders in the ED: A review of best practices, barriers, and future directions. Open Access Emergency Medicine: OAEM, 12, 261–274. https://doi.org/10.2147/OAEM.S267416
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2023). Understanding the Opioid Overdose Epidemic. Retrieved from https://www.cdc.gov/opioids/basics/epidemic.html#print
   Google Scholar
• Chen, Y., Wang, Y., Nielsen, S., Kuhn, L., & Lam, T. (2020). A systematic review of opioid overdose interventions delivered within emergency departments. Drug and Alcohol Dependence, 213, 108009.https://doi.org/10.1016/j.drugalcdep.2020.108009
   PubMed Web of Science ®Google Scholar
• Cooper, S., Cant, R., Kelly, M., Levett-Jones, T., McKenna, L., Seaton, P., & Bogossian, F. (2021). An evidence-based checklist for improving scoping review quality. Clinical Nursing Research, 30(3), 230–240. https://doi.org/10.1177/1054773819846024
   PubMed Web of Science ®Google Scholar
• Dahlem, C. H. G., Scalera, M., Anderson, G., Tasker, M., Ploutz-Snyder, R., McCabe, S. E., & Boyd, C. J. (2021). Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy. Substance Abuse, 42(4), 423–427. https://doi.org/10.1080/08897077.2020.1847239
   PubMed Web of Science ®Google Scholar
• Demuynck, S. (2022). A generation ready for change: Preparing for the deregulation of medications for opioid use disorder in undergraduate medical education. Academic Medicine, 98(4), 440–443. https://doi.org/10.1097/ACM.0000000000004999
   PubMed Web of Science ®Google Scholar
• Dezfulian, C., Orkin, A. M., Maron, B. A., Elmer, J., Girotra, S., Gladwin, M. T., Merchant, R. M., Panchal, A. R., Perman, S. M., Starks, M. A., van Diepen, S., … Lavonas, E. J, Council on Clinical, C. (2021). Opioid-associated out-of-hospital cardiac arrest: Distinctive clinical features and implications for health care and public responses: A scientific statement from the American Heart Association. Circulation, 143(16), e836–e870. https://doi.org/10.1161/CIR.0000000000000958
   PubMed Web of Science ®Google Scholar
• Dong, K. A., Lavergne, K. J., Salvalaggio, G., Weber, S. M., Xue, C. J., Kestler, A., Kaczorowski, J., Orkin, A. M., Pugh, A., & Hyshka, E. (2021). Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study. Journal of the American College of Emergency Physicians Open, 2(2), e12409. https://doi.org/10.1002/emp2.12409
   PubMedGoogle Scholar
• Fockele, C. E., Duber, H. C., Finegood, B., Morse, S. C., & Whiteside, L. K. (2021). Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington. Journal of the American College of Emergency Physicians Open, 2(2), e12408. https://doi.org/10.1002/emp2.12408
   PubMedGoogle Scholar
• Foster, S. D., Lee, K., Edwards, C., Pelullo, A. P., Khatri, U. G., Lowenstein, M., & Perrone, J. (2020). Providing incentive for emergency physician X-Waiver training: An evaluation of program success and postintervention buprenorphine prescribing. Annals of Emergency Medicine, 76(2), 206–214. https://doi.org/10.1016/j.annemergmed.2020.02.020
   PubMed Web of Science ®Google Scholar
• Fox, L., & Nelson, L. S. (2019). Emergency Department Initiation of buprenorphine for opioid use disorder: Current status, and future potential. CNS Drugs, 33(12), 1147–1154. https://doi.org/10.1007/s40263-019-00667-7
   PubMed Web of Science ®Google Scholar
• Grunvald, W., Herrington, R., King, R., Lamberson, M., Mackey, S., Maruti, S., Rawson, R., & Wolfson, D. (2021). COVID-19: A new barrier to treatment for opioid use disorder in the emergency department. Journal of the American College of Emergency Physicians Open, 2(2), e12403. https://doi.org/10.1002/emp2.12403
   PubMedGoogle Scholar
• Guo, C. Z., D’Onofrio, G., Fiellin, D. A., Edelman, E. J., Hawk, K., Herring, A., McCormack, R., Perrone, J., & Cowan, E. (2021). Emergency department-initiated buprenorphine protocols: A national evaluation. Journal of the American College of Emergency Physicians Open, 2(6), e12606. https://doi.org/10.1002/emp2.12606
   PubMedGoogle Scholar
• Hawk, K., Grau, L. E., Fiellin, D. A., Chawarski, M., O’Connor, P. G., Cirillo, N., Breen, C., & D’Onofrio, G. (2021). A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine, 28(5), 542–552. https://doi.org/10.1111/acem.14197
   PubMed Web of Science ®Google Scholar
• Hawk, K., Hoppe, J., Ketcham, E., LaPietra, A., Moulin, A., Nelson, L., Schwarz, E., Shahid, S., Stader, D., Wilson, M. P., & D’Onofrio, G. (2021). Consensus recommendations on the treatment of opioid use disorder in the emergency department. Annals of Emergency Medicine, 78(3), 434–442. https://doi.org/10.1016/j.annemergmed.2021.04.023
   PubMed Web of Science ®Google Scholar
• Hawk, K., McCormack, R., Edelman, E. J., Coupet, E., Toledo, N., Gauthier, P., Rotrosen, J., Chawarski, M., Martel, S., Owens, P., Pantalon, M. V., O’Connor, P., Whiteside, L. K., Cowan, E., Richardson, L. D., Lyons, M. S., Rothman, R., Marsch, L., Fiellin, D. A., & D’Onofrio, G. (2022). Perspectives about emergency department care encounters among adults with opioid use disorder. JAMA Network Open, 5(1), e2144955. https://doi.org/10.1001/jamanetworkopen.2021.44955
   PubMed Web of Science ®Google Scholar
• Heil, J., Ganetsky, V. S., Salzman, M. S., Hunter, K., Baston, K. E., Carroll, G., Ketcham, E., & Haroz, R. (2022). Attitudes on methadone utilization in the emergency department: A physician cross-sectional study. The Western Journal of Emergency Medicine, 23(3), 386–395. https://doi.org/10.5811/westjem.2022.2.54681
   PubMedGoogle Scholar
• Hoyeck, P., Wiercigroch, D., Clarke, C., Moineddin, R., Sheikh, H., & Hulme, J. (2020). Understanding current practice of opioid use disorder management in emergency departments across Canada: A cross-sectional study. CJEM, 22(4), 494–498. https://doi.org/10.1017/cem.2020.362
   PubMedGoogle Scholar
• Im, D. D., Chary, A., Condella, A. L., Vongsachang, H., Carlson, L. C., Vogel, L., Martin, A., Kunzler, N., Weiner, S. G., & Samuels-Kalow, M. (2020). Emergency department clinicians’ attitudes toward opioid use disorder and emergency department-initiated buprenorphine treatment: A mixed-methods study. The Western Journal of Emergency Medicine, 21(2), 261–271. https://doi.org/10.5811/westjem.2019.11.44382
   PubMed Web of Science ®Google Scholar
• Kestler, A., Kaczorowski, J., Dong, K., Orkin, A. M., Daoust, R., Moe, J., Van Pelt, K., Andolfatto, G., Klaiman, M., Yan, J., Koh, J. J., Crowder, K., Webster, D., Atkinson, P., Savage, D., Stempien, J., Besserer, F., Wale, J., Lam, A., & Scheueremeyer, F. (2021). A cross-sectional survey on buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: A cross-sectional survey. CMAJ Open, 9(3), E864–E873. https://doi.org/10.9778/cmajo.20200190
   PubMedGoogle Scholar
• Khatri, U. G., & Perrone, J. (2020). Opioid use disorder and COVID-19: Crashing of the crises. Journal of Addiction Medicine, 14(4), e6–e7. https://doi.org/10.1097/ADM.0000000000000684
   PubMed Web of Science ®Google Scholar
• Kilaru, A. S., Xiong, A., Lowenstein, M., Meisel, Z. F., Perrone, J., Khatri, U., Mitra, N., & Delgado, M. K. (2020). Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Network Open, 3(5), e205852. https://doi.org/10.1001/jamanetworkopen.2020.5852
   PubMed Web of Science ®Google Scholar
• Langabeer, J. R., Champagne-Langabeer, T., Yatsco, A. J., O’Neal, M. M., Cardenas-Turanzas, M., Prater, S., Luber, S., Stotts, A., Fadial, T., Khraish, G., Wang, H., Bobrow, B. J., & Chambers, K. A. (2021). Feasibility and outcomes from an integrated bridge treatment program for opioid use disorder. Journal of the American College of Emergency Physicians Open, 2(2), e12417. https://doi.org/10.1002/emp2.12417
   PubMedGoogle Scholar
• Langabeer, J. R., Stotts, A. L., Bobrow, B. J., Wang, H. E., Chambers, K. A., Yatsco, A. J., Cardenas-Turanzas, M., & Champagne-Langabeer, T. (2021). Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug and Alcohol Dependence, 221, 108568. https://doi.org/10.1016/j.drugalcdep.2021.108568
   PubMed Web of Science ®Google Scholar
• Lapham, G., Boudreau, D. M., Johnson, E. A., Bobb, J. F., Matthews, A. G., McCormack, J., Liu, D., Samet, J. H., Saxon, A. J., Campbell, C. I., Glass, J. E., Rossom, R. C., Murphy, M. T., Binswanger, I. A., Yarborough, B. J. H., & Bradley, K. A, PROUD Collaborative Investigators. (2020). Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug and Alcohol Dependence, 207, 107732. https://doi.org/10.1016/j.drugalcdep.2019.107732
   PubMed Web of Science ®Google Scholar
• Lowenstein, M., Perrone, J., Xiong, R. A., Snider, C. K., O’Donnell, N., Hermann, D., Rosin, R., Dees, J., McFadden, R., Khatri, U., Meisel, Z. F., Mitra, N., & Delgado, M. K. (2022). Sustained implementation of a multicomponent strategy to increase emergency department-initiated interventions for opioid use disorder. Annals of Emergency Medicine, 79(3), 237–248. https://doi.org/10.1016/j.annemergmed.2021.10.012
   PubMed Web of Science ®Google Scholar
• Madden, E. F., Prevedel, S., Light, T., & Sulzer, S. H. (2021). Intervention stigma toward medications for opioid use disorder: A systematic review. Substance Use & Misuse, 56(14), 2181–2201. https://doi.org/10.1080/10826084.2021.1975749
   PubMed Web of Science ®Google Scholar
• Mattle, A. G., Aladeen, T., Blondell, R. D., Capote, H., & Rainka, M. (2021). Evaluating outcomes of a clinical pharmacist medication management program in a multidisciplinary practice for outpatient buprenorphine treatment of opioid use disorder. Journal of the American College of Clinical Pharmacy, 4(4), 424–434. https://doi.org/10.1002/jac5.1405
   Google Scholar
• Mazurenko, O., Andraka-Christou, B. T., Bair, M. J., Kara, A. Y., & Harle, C. A. (2020). Clinical perspectives on hospitals’ role in the opioid epidemic. BMC Health Services Research, 20(1), 521. https://doi.org/10.1186/s12913-020-05390-4
   PubMed Web of Science ®Google Scholar
• McLane, P., Scott, K., Suleman, Z., Yee, K., Holroyd, B. R., Dong, K., Ghosh, S. M., Fanaeian, J., Deol, J., Biggs, C., Lang, E., Hair, H., Ross, M., Tanguay, R., Olmstead, A., Fisher, A., & Fielding, S, Buprenorphine/Naloxone in Emergency Departments Initial Project Team. (2020). Multi-site intervention to improve emergency department care for patients who live with opioid use disorder: A quantitative evaluation. Canadian Journal of Emergency Medicine, 22(6), 784–792. https://doi.org/10.1017/cem.2020.438
   Web of Science ®Google Scholar
• Oldfield, B. J., Edens, E. L., Agnoli, A., Bone, C. W., Cervone, D. J., Edmond, S. N., Manhapra, A., Sellinger, J. J., & Becker, W. C. (2018). Multimodal treatment options, including rotating to buprenorphine, within a multidisciplinary pain clinic for patients on risky opioid regimens: A quality improvement study. Pain Medicine (Malden, Mass.), 19(suppl_1), S38–S45. https://doi.org/10.1093/pm/pny086
   PubMedGoogle Scholar
• Orkin, A. M., Charles, M., Norris, K., Thomas, R., Chapman, L., Wright, A., Campbell, D. M., Handford, C., Klaiman, M., Hopkins, S., Shahin, R., Thorpe, K., Jüni, P., Parsons, J., Sellen, K., Goso, N., Hunt, R., Leece, P., Morrison, L. J., … Strike, C. (2021). Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial. Resuscitation Plus, 6, 100131. https://doi.org/10.1016/j.resplu.2021.100131
   PubMedGoogle Scholar
• Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Systematic Reviews, 10(1), 89. https://doi.org/10.1186/s13643-021-01626-4
   PubMed Web of Science ®Google Scholar
• Patel, E., Solomon, K., Saleem, H., Saloner, B., Pugh, T., Hulsey, E., & Leontsini, E. (2022). Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals. Journal of Substance Abuse Treatment, 136, 108658. https://doi.org/10.1016/j.jsat.2021.108658
   PubMed Web of Science ®Google Scholar
• Reuter, Q. R., Santos, A. D., McKinnon, J., Gothard, D., Jouriles, N., & Seaberg, D. (2022). Long-term treatment retention of an emergency department initiated medication for opioid use disorder program. The American Journal of Emergency Medicine, 55, 98–102. https://doi.org/10.1016/j.ajem.2022.02.041
   PubMed Web of Science ®Google Scholar
• Rowe, C. L., Ahern, J., Hubbard, A., & Coffin, P. O. (2022). Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program. Journal of Substance Abuse Treatment, 132, 108452. https://doi.org/10.1016/j.jsat.2021.108452
   PubMed Web of Science ®Google Scholar
• SAMHSA. (2023). SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD). Retrieved from https://www.samhsa.gov/newsroom/statements/2023/samhsa-applauds-expansion-access-moud
   Google Scholar
• Samuels, E. A., D’Onofrio, G., Huntley, K., Levin, S., Schuur, J. D., Bart, G., Hawk, K., Tai, B., Campbell, C. I., & Venkatesh, A. K. (2019). A quality framework for emergency department treatment of opioid use disorder. Annals of Emergency Medicine, 73(3), 237–247. https://doi.org/10.1016/j.annemergmed.2018.08.439
   PubMed Web of Science ®Google Scholar
• Schimmel, J., & Manini, A. F. (2020). Opioid use disorder and COVID-19: Biological plausibility for worsened outcomes. Substance Use & Misuse, 55(11), 1900–1901. https://doi.org/10.1080/10826084.2020.1791184
   PubMed Web of Science ®Google Scholar
• Schoenfeld, E. M., Soares, W. E., Schaeffer, E. M., Gitlin, J., Burke, K., & Westafer, L. M. (2022). This is part of emergency medicine now: A qualitative assessment of emergency clinicians’ facilitators of and barriers to initiating buprenorphine. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine, 29(1), 28–40. https://doi.org/10.1111/acem.14369
   PubMed Web of Science ®Google Scholar
• Schoenfeld, E. M., Westafer, L. M., Beck, S. A., Potee, B. G., Vysetty, S., Simon, C., Tozloski, J. M., Girardin, A. L., & Soares, W. E. (2022). Just give them a choice: Patients’ perspectives on starting medications for opioid use disorder in the ED. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine, 29(8), 928–943. https://doi.org/10.1111/acem.14507
   PubMed Web of Science ®Google Scholar
• Schoenfeld, E. M., Westafer, L. M., & Soares, W. E., 3rd. (2020). Missed opportunities to save lives-treatments for opioid use disorder after overdose. JAMA Network Open, 3(5), e206369. https://doi.org/10.1001/jamanetworkopen.2020.6369
   PubMed Web of Science ®Google Scholar
• Sokol, R., Tammaro, E., Kim, J. Y., & Stopka, T. J. (2021). Linking MATTERS: Barriers and facilitators to implementing emergency department-initiated buprenorphine-naloxone in patients with opioid use disorder and linkage to long-term care. Substance Use & Misuse, 56(7), 1045–1053. https://doi.org/10.1080/10826084.2021.1906280
   PubMed Web of Science ®Google Scholar
• Spetz, J., Chapman, S., Tierney, M., Phoenix, B., & Hailer, L. (2021). Barriers and facilitators of advanced practice registered nurse participation in medication treatment for opioid use disorder: A mixed methods study. Journal of Nursing Regulation, 12(2), 5–22. https://doi.org/10.1016/s2155-8256(21)00052-1
   Web of Science ®Google Scholar
• Spreen, L. A., Dittmar, E. N., Quirk, K. C., & Smith, M. A. (2022). Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy, 42(5), 411–427. https://doi.org/10.1002/phar.2676
   PubMed Web of Science ®Google Scholar
• Stein, B. D., Saloner, B., Kerber, R., Sorbero, M., & Gordon, A. J. (2022). Subsequent buprenorphine treatment following emergency physician buprenorphine prescription fills: A National Assessment 2019 to 2020. Annals of Emergency Medicine, 79(5), 441–450. https://doi.org/10.1016/j.annemergmed.2022.01.042
   PubMed Web of Science ®Google Scholar
• Stewart, R. E., Cardamone, N. C., Mandell, D. S., Kwon, N., Kampman, K. M., Knudsen, H. K., Tjoa, C. W., & Marcus, S. C. (2022). Not in my treatment center: Leadership’s perception of barriers to MOUD adoption. Journal of Substance Abuse Treatment, 144, 108900. https://doi.org/10.1016/j.jsat.2022.108900
   PubMed Web of Science ®Google Scholar
• Stewart, M. T., Coulibaly, N., Schwartz, D., Dey, J., & Thomas, C. P. (2021). Emergency department-based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches? Journal of Substance Abuse Treatment, 129, 108479. https://doi.org/10.1016/j.jsat.2021.108479
   PubMed Web of Science ®Google Scholar
• Taylor, J. L., & Samet, J. H. (2022). Opioid use disorder. Ann Intern Med, 175(1), ITC1–ITC16. https://doi.org/10.7326/AITC202201180
   PubMed Web of Science ®Google Scholar
• Wiercigroch, D., Hoyeck, P., Sheikh, H., & Hulme, J. (2021). A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department. BMC Emergency Medicine, 21(1), 48. https://doi.org/10.1186/s12873-021-00443-1
   PubMed Web of Science ®Google Scholar